17:
318:
105:
mesothelioma cases. In contrast, only 14% of metastatic adenocarcinomas were positive for CK5/6. Cytokeratin 5/6 also stains reactive mesothelium, which limits its specificity. Overall, CK5/6, along with other markers like calretinin and thrombomodulin, demonstrates high sensitivity for epithelioid mesothelioma, making it a valuable tool in diagnostic pathology.
104:
Cytokeratin 5/6 (CK5/6) is a biomarker that has emerged as a valuable tool in distinguishing epithelioid pleural mesothelioma from metastatic adenocarcinoma. In a study comparing its effectiveness with other markers, CK5/6 showed high sensitivity, staining positively in 92% of epithelioid pleural
209:"Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the Pleura"
86:
and CK5/6 staining could be used in concert to distinguish between the diagnosis of papilloma (Cyclin D1 < 4.20%, CK 5/6 positive) or papillary carcinoma (Cyclin D1 > 37.00%, CK 5/6 negative).
16:
101:
Until recently the diagnostic method predominantly depended on identifying antibodies' responses that are positive for adenocarcinoma and negative for mesothelioma.
359:
393:
150:"An analysis of Cyclin D1, Cytokeratin 5/6 and Cytokeratin 8/18 expression in breast papillomas and papillary carcinomas"
378:
352:
79:
75:
21:
257:
388:
345:
44:
383:
94:
60:
285:
277:
238:
230:
189:
171:
329:
317:
269:
220:
179:
161:
130:
273:
184:
149:
56:
372:
40:
36:
325:
90:
225:
208:
281:
234:
175:
207:
Cury, P M; Butcher, D N; Fisher, C; Corrin, B; Nicholson, A G (2000-02-01).
83:
242:
193:
289:
166:
68:
32:
258:"Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma"
64:
15:
306:
78:(UDH) and papillary lesions (having a mosaic-like pattern) from
24:, showing a mosaic pattern, predominantly in the central zone.
148:
Wang, Yu; Zhu, Jin-fu; Liu, Ying-ying; Han, Gui-ping (2013).
20:
Immunohistochemistry with cytokeratin 5/6 antibodies in
333:
135:
Topic
Completed: 3 June 2019. Revised: 8 December 2019
124:
122:
120:
118:
256:Clover, J.; Oates, J.; Edwards, C. (2003-11-14).
353:
143:
141:
74:For breast pathology, also in distinguishing
8:
360:
346:
224:
183:
165:
89:In the lung, distinguishing epithelioid
51:, including the following applications:
114:
7:
314:
312:
332:. You can help Knowledge (XXG) by
274:10.1046/j.1365-2559.1997.2150833.x
14:
316:
129:Robert Terlević, Semir Vranić.
1:
93:(CK5/6 positive in 83%) from
82:, which is usually negative.
410:
311:
29:Cytokeratin 5/6 antibodies
226:10.1038/modpathol.3880018
97:(CK5/6 negative in 85%).
80:ductal carcinoma in situ
76:usual ductal hyperplasia
22:usual ductal hyperplasia
307:Recombinant Antibodies
25:
167:10.1186/1746-1596-8-8
19:
394:Immunohistochemistry
154:Diagnostic Pathology
45:immunohistochemistry
43:. These are used in
95:lung adenocarcinoma
61:myoepithelial cells
379:Biochemistry stubs
26:
341:
340:
131:"Cytokeratin 5/6"
35:that target both
401:
362:
355:
348:
320:
313:
294:
293:
253:
247:
246:
228:
213:Modern Pathology
204:
198:
197:
187:
169:
145:
136:
134:
126:
409:
408:
404:
403:
402:
400:
399:
398:
369:
368:
367:
366:
303:
298:
297:
255:
254:
250:
206:
205:
201:
147:
146:
139:
128:
127:
116:
111:
49:CK 5/6 staining
47:, often called
12:
11:
5:
407:
405:
397:
396:
391:
386:
381:
371:
370:
365:
364:
357:
350:
342:
339:
338:
321:
310:
309:
302:
301:External links
299:
296:
295:
268:(2): 140–143.
262:Histopathology
248:
219:(2): 107–112.
199:
137:
113:
112:
110:
107:
99:
98:
87:
72:
13:
10:
9:
6:
4:
3:
2:
406:
395:
392:
390:
387:
385:
382:
380:
377:
376:
374:
363:
358:
356:
351:
349:
344:
343:
337:
335:
331:
328:article is a
327:
322:
319:
315:
308:
305:
304:
300:
291:
287:
283:
279:
275:
271:
267:
263:
259:
252:
249:
244:
240:
236:
232:
227:
222:
218:
214:
210:
203:
200:
195:
191:
186:
181:
177:
173:
168:
163:
159:
155:
151:
144:
142:
138:
132:
125:
123:
121:
119:
115:
108:
106:
102:
96:
92:
88:
85:
81:
77:
73:
70:
66:
62:
58:
54:
53:
52:
50:
46:
42:
41:cytokeratin 6
38:
37:cytokeratin 5
34:
30:
23:
18:
389:Biochemistry
334:expanding it
326:biochemistry
323:
265:
261:
251:
216:
212:
202:
157:
153:
103:
100:
91:mesothelioma
55:Identifying
48:
28:
27:
57:basal cells
384:Antibodies
373:Categories
109:References
33:antibodies
282:0309-0167
235:0893-3952
176:1746-1596
84:Cyclin D1
243:10697265
194:23327593
160:(1): 8.
69:prostate
290:9279564
185:3571902
63:in the
288:
280:
241:
233:
192:
182:
174:
65:breast
324:This
330:stub
286:PMID
278:ISSN
239:PMID
231:ISSN
190:PMID
172:ISSN
67:and
39:and
31:are
270:doi
221:doi
180:PMC
162:doi
59:or
375::
284:.
276:.
266:31
264:.
260:.
237:.
229:.
217:13
215:.
211:.
188:.
178:.
170:.
156:.
152:.
140:^
117:^
361:e
354:t
347:v
336:.
292:.
272::
245:.
223::
196:.
164::
158:8
133:.
71:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
